Did the tobacco industry know that smoking caused cystic fibrosis-like lung disease before the scientific community?

Elif Dagli (Istanbul, Turkey), Elif Dagli

Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards
Session: Emerging data on (e-)cigarettes and their health hazards
Session type: Oral Presentation
Number: 281
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Elif Dagli (Istanbul, Turkey), Elif Dagli. Did the tobacco industry know that smoking caused cystic fibrosis-like lung disease before the scientific community?. Eur Respir J 2015; 46: Suppl. 59, 281

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Physical activity for cystic fibrosis: perceptions of people with cystic fibrosis, parents and healthcare professionals
Source: ERJ Open Res, 6 (3) 00294-2019; 10.1183/23120541.00294-2019
Year: 2020



Impact of smoke-free workplace legislation on exposures and health: possibilities for prevention
Source: Eur Respir J 2006; 28: 397-408
Year: 2006



Smoking and the lung
Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=60
Year: 2002

Assessment of public awareness on COPD in Singapore in a one-day awareness campaign
Source: International Congress 2016 – Public health related concerns and epidemiology of smoking and smoking-related products
Year: 2016


Health care system resource utilisation in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

Is electronic-cigarette a tobacco industry discovery?
Source: International Congress 2015 – E-cigarette, sisha and waterpipe
Year: 2015


Do physicians in primary health care recognize pulmonary fibrosis?
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


Pulmonary and systemic manifestations in asymptomatic smokers
Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases
Year: 2016


Assessment of general physicians’ knowledge in the public and private sectors about interstitial lung disease.
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017


Workplace smoking restriction and respiratory health: the Irish experience
Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease
Year: 2005

Smoking and lung function among adults with newly-onset asthma
Source: International Congress 2016 – Smoking-related diseases
Year: 2016

Public awareness on cystic fibrosis: results from a national pragmatic survey
Source: Eur Respir J 2015; 46: 264-267
Year: 2015


Clinical, functional and microbiological characteristics of an adult brazilian cystic fibrosis population
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014


The prevalence and impact of cannabis smoking in clinical trial patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015


Environmental tobacco smoke and health in the elderly
Source: Eur Respir J 2002; 19: 172-181
Year: 2002



Incidence and prevalence of IPF in an insurance claims database: Assessing accuracy using medical records
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014


Respiratory effects of cannabis smoking: A literature review
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016


The effect of transition from a paediatric to adult cystic fibrosis (CF) centre on clinical status and hospital attendance
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016